960 Randomized multicenter study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer
Late-Breaking Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1010-A1010
10.1136/jitc-2021-sitc2021.960